Sublingual Immunotherapy for Peanut Allergy and Induction of Tolerance
Status:
Completed
Trial end date:
2018-04-16
Target enrollment:
Participant gender:
Summary
The goal of this study will be to increase the reaction threshold (desensitization) of peanut
allergic children using peanut sublingual immunotherapy and to determine if the nonreactive
state of the immune system persists after treatment has been discontinued (tolerance).
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
University of North Carolina, Chapel Hill
Collaborator:
National Center for Complementary and Integrative Health (NCCIH)